Company profilePharmaceutical#468 of 1,318 in Pakistan✓ No DRAP alerts

Nouveaux Pharma Limited

Pharmaceutical company · 31 brands · 14 molecules

31 registered products 29 pharmaceutical brands 14 distinct molecules 0 DRAP alerts

Company overview

31
registered products
29
pharmaceutical brands
14
distinct molecules
0
therapeutic classes
0
DRAP alerts

Nouveaux Pharma Limited is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 31 product registrations across 14 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Nouveaux

2 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

2
ceilings with an approval date
1
not revised in 2+ years
2024
oldest approval year
20241
20261
Longest without revision

Top molecules by brand count

Octreotide5 brands
Everolimus4 brands
Deferasirox3 brands
Ciclosporin3 brands
Nilotinib3 brands
Tobramycin1 brand
Travoprost1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official31 products · Rs 91.18 – Rs 1,011,438.15
Median across source: Rs 16,159.11

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Novartis Pharmaceuticals (Pvt) Ltd. holds 74 molecules not in this portfolio
AceclofenacAmlodipineAzithromycinBenzalkoniumBrinzolamideCaffeine
SHAIGAN PHARMACEUTICALS (PVT) LTD. holds 139 molecules not in this portfolio
AlbendazoleAmikacinAmlodipineAmlodipine BasylateArtemetherAscorbic Acid
BIO LABS (PVT) LTD. holds 139 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate

Get the full profile for Nouveaux

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.